Overview
Brain tumors can present with unique challenges including epileptic seizures, potential adverse effects from medications, physical disability, and neurocognitive disturbances 1. Management strategies are not standardized and can vary among specialists 1.Diagnosis
No specific diagnostic criteria or grading systems are mentioned in the provided abstracts.Management
Antiepileptic Drugs (AEDs):
* Avoid enzyme-inducing AEDs due to potential interference with antineoplastic drugs 1.
* Consider newer generation AEDs such as levetiracetam, lamotrigine, and topiramate as first-choice options 1.
* Valproic acid is also a consideration 1.
* Histological type or tumor localization does not appear to affect AED response 1.
Prophylaxis: Both short-term and long-term prophylaxis are discussed, but specific details are not provided 1.Special Populations
No specific information is provided regarding special populations such as pregnancy, pediatrics, elderly, or comorbidities.Key Recommendations
Avoid enzyme-inducing antiepileptic drugs due to interference with antitumoral drugs 1. (Evidence: Expert opinion)
Consider newer generation antiepileptic drugs, including levetiracetam, lamotrigine, and topiramate, as first-choice options for managing epilepsy in brain tumors 1. (Evidence: Expert opinion)
Valproic acid should also be considered for managing epilepsy in brain tumors 1. (Evidence: Expert opinion)References
1 Maschio M, Aguglia U, Avanzini G, Banfi P, Buttinelli C, Capovilla G et al.. Management of epilepsy in brain tumors. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019. link